$ABBV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AbbVie Inc.. Get notifications about new insider transactions in AbbVie Inc. for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2015 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 60.51 | 2,074 | 125,492 | 123,860 | 125.9 K to 123.9 K (-1.65 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 60.52 | 6,128 | 370,867 | 125,934 | 132.1 K to 125.9 K (-4.64 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 60.50 | 1,862 | 112,651 | 68,460 | 70.3 K to 68.5 K (-2.65 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Sell | S | 60.57 | 1,185 | 71,777 | 70,322 | 71.5 K to 70.3 K (-1.66 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 60.52 | 2,524 | 152,752 | 71,507 | 74 K to 71.5 K (-3.41 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 60.50 | 8,192 | 495,616 | 218,028 | 226.2 K to 218 K (-3.62 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 60.52 | 10,299 | 623,295 | 226,220 | 236.5 K to 226.2 K (-4.35 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 60.50 | 7,200 | 435,600 | 236,812 | 244 K to 236.8 K (-2.95 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 60.52 | 12,706 | 768,967 | 244,012 | 256.7 K to 244 K (-4.95 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 58.88 | 21,390 | 1,259,443 | 21,390 | |
Feb 23 2015 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Grant | A | 0.00 | 10,820 | 0 | 74,031 | 63.2 K to 74 K (+17.12 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | A | 58.88 | 327,290 | 19,270,835 | 327,290 | |
Feb 23 2015 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 165,590 | 0 | 551,918 | 386.3 K to 551.9 K (+42.86 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 58.88 | 110,770 | 6,522,138 | 110,770 | |
Feb 23 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 56,040 | 0 | 236,519 | 180.5 K to 236.5 K (+31.05 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 58.88 | 101,960 | 6,003,405 | 101,960 | |
Feb 23 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 51,580 | 0 | 256,718 | 205.1 K to 256.7 K (+25.14 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Option Exercise | A | 58.88 | 104,480 | 6,151,782 | 104,480 | |
Feb 23 2015 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 52,860 | 0 | 194,485 | 141.6 K to 194.5 K (+37.32 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | A | 58.88 | 52,870 | 3,112,986 | 52,870 | |
Feb 23 2015 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Grant | A | 0.00 | 26,740 | 0 | 112,568 | 85.8 K to 112.6 K (+31.16 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | A | 58.88 | 103,220 | 6,077,594 | 103,220 | |
Feb 23 2015 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Grant | A | 0.00 | 52,220 | 0 | 325,017 | 272.8 K to 325 K (+19.14 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Option Exercise | A | 58.88 | 50,350 | 2,964,608 | 50,350 | |
Feb 23 2015 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Grant | A | 0.00 | 25,470 | 0 | 132,062 | 106.6 K to 132.1 K (+23.89 %) |
Feb 19 2015 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 58.70 | 241 | 14,147 | 106,592 | 106.8 K to 106.6 K (-0.23 %) |
Feb 19 2015 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 58.05 | 551 | 31,986 | 106,833 | 107.4 K to 106.8 K (-0.51 %) |
Feb 11 2015 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 24.07 | 2,250 | 54,164 | 0 | |
Feb 11 2015 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 56.90 | 1,425 | 81,083 | 1,743 | 3.2 K to 1.7 K (-44.98 %) |
Feb 11 2015 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 24.07 | 2,250 | 54,164 | 3,168 | 918 to 3.2 K (+245.10 %) |
Jan 05 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 527 | 0 | 20,068 | |
Jan 05 2015 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 504 | 0 | 5,432 | |
Jan 05 2015 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 527 | 0 | 11,963 | |
Jan 05 2015 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 120 | 0 | 3,887 | |
Dec 22 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 24.07 | 8,495 | 204,501 | 0 | |
Dec 22 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 68.00 | 8,495 | 577,660 | 180,068 | 188.6 K to 180.1 K (-4.51 %) |
Dec 22 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 24.07 | 8,495 | 204,501 | 188,563 | 180.1 K to 188.6 K (+4.72 %) |
Nov 26 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Gift | G | 0.00 | 788 | 0 | 272,797 | 273.6 K to 272.8 K (-0.29 %) |
Nov 26 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Sell | S | 67.82 | 100 | 6,782 | 63,211 | 63.3 K to 63.2 K (-0.16 %) |
Nov 26 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Sell | S | 67.81 | 1,400 | 94,936 | 63,311 | 64.7 K to 63.3 K (-2.16 %) |
Nov 26 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 9,075 | 0 | 386,328 | 395.4 K to 386.3 K (-2.30 %) |
Nov 07 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 24.07 | 10,000 | 240,700 | 0 | |
Nov 07 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 62.54 | 6,737 | 421,332 | 64,711 | 71.4 K to 64.7 K (-9.43 %) |
Nov 07 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 24.07 | 10,000 | 240,731 | 71,448 | 61.4 K to 71.4 K (+16.27 %) |
Oct 02 2014 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 597 | 0 | 19,414 | |
Oct 02 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 597 | 0 | 11,361 | |
Oct 02 2014 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 571 | 0 | 4,896 | |
Oct 02 2014 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 136 | 0 | 3,742 | |
Jul 02 2014 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 611 | 0 | 18,671 | |
Jul 02 2014 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 584 | 0 | 4,291 | |
Jul 02 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 611 | 0 | 10,681 | |
Jul 02 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 671 | 0 | 9,990 | |
Jul 02 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 653 | 0 | 9,246 | |
Jul 02 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 771 | 0 | 8,522 | |
Jul 02 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 834 | 0 | 7,680 | |
Jul 02 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 846 | 0 | 6,786 | |
Jun 04 2014 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Option Exercise | A | 54.44 | 74,309 | 4,045,382 | 74,309 | |
Jun 04 2014 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 141,625 | 0 | 141,625 | 0 to 141.6 K |
May 13 2014 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 2,764 | 0 | 7,299 | 4.5 K to 7.3 K (+60.95 %) |
May 13 2014 | ABBV | AbbVie Inc. | ROBERTS ROY S | Director | Grant | A | 0.00 | 2,764 | 0 | 25,299 | 22.5 K to 25.3 K (+12.27 %) |
May 13 2014 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,764 | 0 | 24,505 | 21.7 K to 24.5 K (+12.71 %) |
May 13 2014 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Grant | A | 0.00 | 2,764 | 0 | 10,420 | 7.7 K to 10.4 K (+36.10 %) |
May 13 2014 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 2,764 | 0 | 7,799 | 5 K to 7.8 K (+54.90 %) |
May 13 2014 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 2,764 | 0 | 5,299 | 2.5 K to 5.3 K (+109.03 %) |
May 13 2014 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 2,764 | 0 | 28,365 | 25.6 K to 28.4 K (+10.80 %) |
May 13 2014 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,764 | 0 | 13,858 | 11.1 K to 13.9 K (+24.91 %) |
Apr 02 2014 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 671 | 0 | 3,844 | |
Apr 02 2014 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 642 | 0 | 3,677 | |
Apr 02 2014 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 153 | 0 | 877 | |
Mar 04 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Sell | S | 50.03 | 2,500 | 125,085 | 273,585 | 276.1 K to 273.6 K (-0.91 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Sell | S | 50.03 | 100 | 5,003 | 276,085 | 276.2 K to 276.1 K (-0.04 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Sell | S | 50.03 | 1,543 | 77,196 | 276,185 | 277.7 K to 276.2 K (-0.56 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Payment of Exercise | F | 50.91 | 21,940 | 1,116,965 | 277,728 | 299.7 K to 277.7 K (-7.32 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 50.26 | 100 | 5,026 | 85,828 | 85.9 K to 85.8 K (-0.12 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 50.26 | 200 | 10,053 | 85,928 | 86.1 K to 85.9 K (-0.23 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 50.26 | 100 | 5,026 | 86,128 | 86.2 K to 86.1 K (-0.12 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 50.25 | 100 | 5,025 | 86,228 | 86.3 K to 86.2 K (-0.12 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 50.25 | 581 | 29,195 | 86,328 | 86.9 K to 86.3 K (-0.67 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 50.25 | 1,200 | 60,295 | 86,909 | 88.1 K to 86.9 K (-1.36 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 50.24 | 162 | 8,139 | 88,109 | 88.3 K to 88.1 K (-0.18 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 51.91 | 6,336 | 328,902 | 88,271 | 94.6 K to 88.3 K (-6.70 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 50.91 | 6,669 | 339,519 | 107,384 | 114.1 K to 107.4 K (-5.85 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 50.91 | 3,360 | 171,058 | 61,448 | 64.8 K to 61.4 K (-5.18 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 51.21 | 500 | 25,607 | 395,403 | 395.9 K to 395.4 K (-0.13 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 51.20 | 2,230 | 114,176 | 395,903 | 398.1 K to 395.9 K (-0.56 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 51.20 | 1,800 | 92,153 | 398,133 | 399.9 K to 398.1 K (-0.45 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 51.19 | 269 | 13,770 | 399,933 | 400.2 K to 399.9 K (-0.07 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 50.91 | 46,811 | 2,383,148 | 400,202 | 447 K to 400.2 K (-10.47 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 51.20 | 100 | 5,120 | 180,068 | 180.2 K to 180.1 K (-0.06 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 50.19 | 1,400 | 70,272 | 180,168 | 181.6 K to 180.2 K (-0.77 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 50.19 | 2,448 | 122,868 | 181,568 | 184 K to 181.6 K (-1.33 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 51.91 | 9,873 | 512,507 | 184,016 | 193.9 K to 184 K (-5.09 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 600 | 30,056 | 205,138 | 205.7 K to 205.1 K (-0.29 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 400 | 20,036 | 205,738 | 206.1 K to 205.7 K (-0.19 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 282 | 14,125 | 206,138 | 206.4 K to 206.1 K (-0.14 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 1,600 | 80,138 | 206,420 | 208 K to 206.4 K (-0.77 %) |
Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 50.91 | 15,319 | 779,890 | 208,020 | 223.3 K to 208 K (-6.86 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | A | 51.42 | 51,990 | 2,673,326 | 51,990 | |
Feb 24 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Grant | A | 0.00 | 30,140 | 0 | 94,607 | 64.5 K to 94.6 K (+46.75 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | A | 51.42 | 94,140 | 4,840,679 | 94,140 | |
Feb 24 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Gift | G | 0.00 | 3,125 | 0 | 299,668 | 302.8 K to 299.7 K (-1.03 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Grant | A | 0.00 | 54,590 | 0 | 302,793 | 248.2 K to 302.8 K (+21.99 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 51.42 | 21,070 | 1,083,419 | 21,070 | |
Feb 24 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Grant | A | 0.00 | 12,220 | 0 | 64,808 | 52.6 K to 64.8 K (+23.24 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Option Exercise | A | 51.42 | 51,990 | 2,673,326 | 51,990 | |
Feb 24 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Grant | A | 0.00 | 30,140 | 0 | 114,053 | 83.9 K to 114.1 K (+35.92 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | A | 51.42 | 281,030 | 14,450,563 | 281,030 | |
Feb 24 2014 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 162,960 | 0 | 447,013 | 284.1 K to 447 K (+57.37 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 51.42 | 92,740 | 4,768,691 | 92,740 | |
Feb 24 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 53,770 | 0 | 193,889 | 140.1 K to 193.9 K (+38.37 %) |
Feb 24 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 51.42 | 81,500 | 4,190,730 | 81,500 | |
Feb 24 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 47,260 | 0 | 223,339 | 176.1 K to 223.3 K (+26.84 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | M | 43.21 | 8,928 | 385,779 | 0 | |
Feb 19 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Payment of Exercise | F | 50.73 | 8,021 | 406,905 | 248,203 | 256.2 K to 248.2 K (-3.13 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Buy | M | 43.21 | 8,928 | 385,779 | 256,224 | 247.3 K to 256.2 K (+3.61 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 51.24 | 200 | 10,247 | 83,913 | 84.1 K to 83.9 K (-0.24 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 51.23 | 265 | 13,575 | 84,113 | 84.4 K to 84.1 K (-0.31 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 50.73 | 558 | 28,307 | 84,378 | 84.9 K to 84.4 K (-0.66 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 50.73 | 534 | 27,090 | 84,936 | 85.5 K to 84.9 K (-0.62 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 44.93 | 9,138 | 410,570 | 0 | |
Feb 19 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 50.73 | 8,428 | 427,552 | 52,588 | 61 K to 52.6 K (-13.81 %) |
Feb 19 2014 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 44.93 | 9,138 | 410,570 | 61,016 | 51.9 K to 61 K (+17.61 %) |
Feb 12 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 45.06 | 1,466 | 66,058 | 0 | |
Feb 12 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 48.89 | 1,389 | 67,908 | 64,467 | 65.9 K to 64.5 K (-2.11 %) |
Feb 12 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 45.06 | 1,466 | 66,058 | 65,856 | 64.4 K to 65.9 K (+2.28 %) |
Feb 07 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 47.78 | 560 | 26,757 | 85,470 | 86 K to 85.5 K (-0.65 %) |
Feb 07 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 47.78 | 200 | 9,557 | 86,030 | 86.2 K to 86 K (-0.23 %) |
Feb 07 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 47.79 | 700 | 33,450 | 86,230 | 86.9 K to 86.2 K (-0.81 %) |
Feb 07 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 47.84 | 387 | 18,512 | 64,390 | 64.8 K to 64.4 K (-0.60 %) |
Feb 07 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 47.85 | 300 | 14,354 | 64,777 | 65.1 K to 64.8 K (-0.46 %) |
Feb 04 2014 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 49.23 | 3,235 | 159,259 | 86,930 | 90.2 K to 86.9 K (-3.59 %) |
Jan 07 2014 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 51.98 | 1,626 | 84,519 | 65,077 | 66.7 K to 65.1 K (-2.44 %) |
Jan 03 2014 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 653 | 0 | 3,148 | |
Jan 03 2014 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 624 | 0 | 3,011 | |
Jan 03 2014 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 149 | 0 | 718 | |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 35.99 | 3,438 | 123,716 | 0 | |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 35.24 | 1,591 | 56,070 | 0 | |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 34.49 | 1,620 | 55,872 | 0 | |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 28.97 | 963 | 27,895 | 0 | |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 54.32 | 6,149 | 334,014 | 140,119 | 146.3 K to 140.1 K (-4.20 %) |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 35.99 | 3,438 | 123,716 | 146,268 | 142.8 K to 146.3 K (+2.41 %) |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 35.24 | 1,591 | 56,070 | 142,830 | 141.2 K to 142.8 K (+1.13 %) |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 34.49 | 1,620 | 55,872 | 141,239 | 139.6 K to 141.2 K (+1.16 %) |
Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 28.97 | 963 | 27,895 | 139,619 | 138.7 K to 139.6 K (+0.69 %) |
Dec 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 28.41 | 2,186 | 62,095 | 0 | |
Dec 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 28.37 | 304 | 8,626 | 0 | |
Dec 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 54.32 | 1,682 | 91,366 | 918 | 2.6 K to 918 (-64.69 %) |
Dec 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 28.41 | 2,186 | 62,095 | 2,600 | 414 to 2.6 K (+528.02 %) |
Dec 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 28.37 | 304 | 8,626 | 414 | 110 to 414 (+276.36 %) |
Nov 21 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 24.07 | 2,158 | 51,950 | 0 |